Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Alzheimer’s Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
VTV Therapeutics
Janssen Pharmaceutical
Merck & Co Inc
GE healthcare
AstraZeneca
Novartis AG
Hoffman-La Roche Ltd
H Lundbeck A/S
Teva Pharmaceuticals Industries Ltd
Eisai Co Ltd
TauRx Pharmaceuticals Ltd
Eli Lilly And Company
AC Immune
Pfizer, Inc
Actavis plc
By Type:
Donepezil
Rivastigmine
Memantine
By Application:
Retail Pharmacies
E-commerce
Hospital Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Alzheimer’s Therapeutics Market Overview 2018-2029
-
1.1 China Alzheimer’s Therapeutics Industry Development Overview
-
1.2 China Alzheimer’s Therapeutics Industry Development History
-
1.3 China Alzheimer’s Therapeutics Industry Market Size (2018-2029)
-
1.4 China Alzheimer’s Therapeutics Market Analysis by Type from Production Side
-
1.4.1 China Alzheimer’s Therapeutics Production Volume, Production Value and Growth Rate of Donepezil (2018-2029)
-
1.4.2 China Alzheimer’s Therapeutics Production Volume, Production Value and Growth Rate of Rivastigmine (2018-2029)
-
1.4.3 China Alzheimer’s Therapeutics Production Volume, Production Value and Growth Rate of Memantine (2018-2029)
-
1.5 China Alzheimer’s Therapeutics Market Analysis by Application from Consumption End
-
1.5.1 China Alzheimer’s Therapeutics Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.5.2 China Alzheimer’s Therapeutics Sales Volume, Sales Value and Growth Rate of E-commerce (2018-2029)
-
1.5.3 China Alzheimer’s Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.6 China Alzheimer’s Therapeutics Market Analysis by Region
-
1.6.1 North China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
Chapter 2 China Alzheimer’s Therapeutics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Alzheimer’s Therapeutics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Alzheimer’s Therapeutics Market Status and Competition Analysis in 2023
-
2.2.3 China Alzheimer’s Therapeutics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Alzheimer’s Therapeutics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Alzheimer’s Therapeutics Industry Development
Chapter 3 Alzheimer’s TherapeuticsIndustry Chain Analysis
-
3.1 Alzheimer’s Therapeutics Industry Chain
-
3.2 Alzheimer’s Therapeutics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Alzheimer’s Therapeutics Market
-
3.3 Alzheimer’s Therapeutics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Alzheimer’s Therapeutics Market
Chapter 4 China Alzheimer’s Therapeutics Market, by Type
-
4.1 China Alzheimer’s Therapeutics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Alzheimer’s Therapeutics Total Production Volume and Growth Rate from Production Side
-
4.5 China Alzheimer’s Therapeutics Production Volume and Growth Rate, by Type
-
4.5.1 China Alzheimer’s Therapeutics Production Volume and Growth Rate of Donepezil
-
4.5.2 China Alzheimer’s Therapeutics Production Volume and Growth Rate of Rivastigmine
-
4.5.3 China Alzheimer’s Therapeutics Production Volume and Growth Rate of Memantine
Chapter 5 China Alzheimer’s Therapeutics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Alzheimer’s Therapeutics Total Market Size and Growth Rate from Consumption End
-
5.5 China Alzheimer’s Therapeutics Market Size and Growth Rate, by Application
-
5.5.1 China Alzheimer’s Therapeutics Market Size and Growth Rate of Retail Pharmacies
-
5.5.2 China Alzheimer’s Therapeutics Market Size and Growth Rate of E-commerce
-
5.5.3 China Alzheimer’s Therapeutics Market Size and Growth Rate of Hospital Pharmacies
Chapter 6 China Alzheimer’s Therapeutics Market, by Region
-
6.1 China Alzheimer’s Therapeutics Production Volume and Production Value, by Region
-
6.2 China Alzheimer’s Therapeutics Sales Volume and Sales Value, by Region
Chapter 7 North China Alzheimer’s Therapeutics Market Analysis
-
7.1 North China Alzheimer’s Therapeutics Market, by Type
-
7.2 North China Alzheimer’s Therapeutics Market, by Application
Chapter 8 Central China Alzheimer’s Therapeutics Market Analysis
-
8.1 Central China Alzheimer’s Therapeutics Market, by Type
-
8.2 Central China Alzheimer’s Therapeutics Market, by Application
Chapter 9 South China Alzheimer’s Therapeutics Market Analysis
-
9.1 South China Alzheimer’s Therapeutics Market, by Type
-
9.2 South China Alzheimer’s Therapeutics Market, by Application
Chapter 10 East China Alzheimer’s Therapeutics Market Analysis
-
10.1 East China Alzheimer’s Therapeutics Market, by Type
-
10.2 East China Alzheimer’s Therapeutics Market, by Application
Chapter 11 Northeast China Alzheimer’s Therapeutics Market Analysis
-
11.1 Northeast China Alzheimer’s Therapeutics Market, by Type
-
11.2 Northeast China Alzheimer’s Therapeutics Market, by Application
Chapter 12 Southwest China Alzheimer’s Therapeutics Market Analysis
-
12.1 Southwest China Alzheimer’s Therapeutics Market, by Type
-
12.2 Southwest China Alzheimer’s Therapeutics Market, by Application
Chapter 13 Northwest China Alzheimer’s Therapeutics Market Analysis
-
13.1 Northwest China Alzheimer’s Therapeutics Market, by Type
-
13.2 Northwest China Alzheimer’s Therapeutics Market, by Application
Chapter 14 Company Profiles
-
14.1 VTV Therapeutics
-
14.1.1 VTV Therapeutics Company Profile
-
14.1.2 VTV Therapeutics Alzheimer’s Therapeutics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Janssen Pharmaceutical
-
14.2.1 Janssen Pharmaceutical Company Profile
-
14.2.2 Janssen Pharmaceutical Alzheimer’s Therapeutics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Merck & Co Inc
-
14.3.1 Merck & Co Inc Company Profile
-
14.3.2 Merck & Co Inc Alzheimer’s Therapeutics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 GE healthcare
-
14.4.1 GE healthcare Company Profile
-
14.4.2 GE healthcare Alzheimer’s Therapeutics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Profile
-
14.5.2 AstraZeneca Alzheimer’s Therapeutics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Novartis AG
-
14.6.1 Novartis AG Company Profile
-
14.6.2 Novartis AG Alzheimer’s Therapeutics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Hoffman-La Roche Ltd
-
14.7.1 Hoffman-La Roche Ltd Company Profile
-
14.7.2 Hoffman-La Roche Ltd Alzheimer’s Therapeutics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 H Lundbeck A/S
-
14.8.1 H Lundbeck A/S Company Profile
-
14.8.2 H Lundbeck A/S Alzheimer’s Therapeutics Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Teva Pharmaceuticals Industries Ltd
-
14.9.1 Teva Pharmaceuticals Industries Ltd Company Profile
-
14.9.2 Teva Pharmaceuticals Industries Ltd Alzheimer’s Therapeutics Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Eisai Co Ltd
-
14.10.1 Eisai Co Ltd Company Profile
-
14.10.2 Eisai Co Ltd Alzheimer’s Therapeutics Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 TauRx Pharmaceuticals Ltd
-
14.11.1 TauRx Pharmaceuticals Ltd Company Profile
-
14.11.2 TauRx Pharmaceuticals Ltd Alzheimer’s Therapeutics Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Eli Lilly And Company
-
14.12.1 Eli Lilly And Company Company Profile
-
14.12.2 Eli Lilly And Company Alzheimer’s Therapeutics Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 AC Immune
-
14.13.1 AC Immune Company Profile
-
14.13.2 AC Immune Alzheimer’s Therapeutics Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Pfizer, Inc
-
14.14.1 Pfizer, Inc Company Profile
-
14.14.2 Pfizer, Inc Alzheimer’s Therapeutics Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Actavis plc
-
14.15.1 Actavis plc Company Profile
-
14.15.2 Actavis plc Alzheimer’s Therapeutics Market Performance
-
14.15.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Alzheimer’s Therapeutics Industry Research Conclusions
-
15.2 Alzheimer’s Therapeutics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Alzheimer’s Therapeutics Industry Market Size (2018-2029)
-
Figure China Alzheimer’s Therapeutics Production Volume, Production Value and Growth Rate of Donepezil (2018-2029)
-
Figure China Alzheimer’s Therapeutics Production Volume, Production Value and Growth Rate of Rivastigmine (2018-2029)
-
Figure China Alzheimer’s Therapeutics Production Volume, Production Value and Growth Rate of Memantine (2018-2029)
-
Figure China Alzheimer’s Therapeutics Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure China Alzheimer’s Therapeutics Sales Volume, Sales Value and Growth Rate of E-commerce (2018-2029)
-
Figure China Alzheimer’s Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure North China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Central China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure South China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure East China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Alzheimer’s Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Alzheimer’s Therapeutics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Alzheimer’s Therapeutics Market Share by Type in 2018
-
Figure China Alzheimer’s Therapeutics Market Share by Type in 2023
-
Figure China Alzheimer’s Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Alzheimer’s Therapeutics Production Volume and Growth Rate of Donepezil (2018-2023)
-
Figure China Alzheimer’s Therapeutics Production Volume and Growth Rate of Rivastigmine (2018-2023)
-
Figure China Alzheimer’s Therapeutics Production Volume and Growth Rate of Memantine (2018-2023)
-
Figure China Alzheimer’s Therapeutics Market Share by Application in 2018
-
Figure China Alzheimer’s Therapeutics Market Share by Application in 2023
-
Figure China Alzheimer’s Therapeutics Total Market Size and Growth Rate from Consumption End
-
Figure China Alzheimer’s Therapeutics Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Figure China Alzheimer’s Therapeutics Market Size and Growth Rate of E-commerce (2018-2023)
-
Figure China Alzheimer’s Therapeutics Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Table China Alzheimer’s Therapeutics Production Volume by Region (2018-2023)
-
Table China Alzheimer’s Therapeutics Production Volume Share by Region (2018-2023)
-
Figure China Alzheimer’s Therapeutics Production Volume Share by Region (2018-2023)
-
Table China Alzheimer’s Therapeutics Production Value by Region (2018-2023)
-
Table China Alzheimer’s Therapeutics Production Value Share by Region (2018-2023)
-
Figure China Alzheimer’s Therapeutics Production Value Share by Region (2018-2023)
-
Table China Alzheimer’s Therapeutics Sales Volume by Region (2018-2023)
-
Table China Alzheimer’s Therapeutics Sales Volume Share by Region (2018-2023)
-
Figure China Alzheimer’s Therapeutics Sales Volume Share by Region (2018-2023)
-
Table China Alzheimer’s Therapeutics Sales Value by Region (2018-2023)
-
Table China Alzheimer’s Therapeutics Sales Value Share by Region (2018-2023)
-
Figure China Alzheimer’s Therapeutics Sales Value Share by Region (2018-2023)
-
Table North China Alzheimer’s Therapeutics Production Volume by Type (2018-2023)
-
Table North China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Figure North China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Table North China Alzheimer’s Therapeutics Sales Volume by Application (2018-2023)
-
Table North China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure North China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Central China Alzheimer’s Therapeutics Production Volume by Type (2018-2023)
-
Table Central China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Central China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Table Central China Alzheimer’s Therapeutics Sales Volume by Application (2018-2023)
-
Table Central China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Central China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Table South China Alzheimer’s Therapeutics Production Volume by Type (2018-2023)
-
Table South China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Figure South China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Table South China Alzheimer’s Therapeutics Sales Volume by Application (2018-2023)
-
Table South China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure South China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Table East China Alzheimer’s Therapeutics Production Volume by Type (2018-2023)
-
Table East China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Figure East China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Table East China Alzheimer’s Therapeutics Sales Volume by Application (2018-2023)
-
Table East China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure East China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Alzheimer’s Therapeutics Production Volume by Type (2018-2023)
-
Table Northeast China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northeast China Alzheimer’s Therapeutics Sales Volume by Application (2018-2023)
-
Table Northeast China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Alzheimer’s Therapeutics Production Volume by Type (2018-2023)
-
Table Southwest China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Table Southwest China Alzheimer’s Therapeutics Sales Volume by Application (2018-2023)
-
Table Southwest China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Alzheimer’s Therapeutics Production Volume by Type (2018-2023)
-
Table Northwest China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Alzheimer’s Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northwest China Alzheimer’s Therapeutics Sales Volume by Application (2018-2023)
-
Table Northwest China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Alzheimer’s Therapeutics Sales Volume Share by Application (2018-2023)
-
Table VTV Therapeutics Company Profile
-
Table VTV Therapeutics Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Janssen Pharmaceutical Company Profile
-
Table Janssen Pharmaceutical Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Merck & Co Inc Company Profile
-
Table Merck & Co Inc Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table GE healthcare Company Profile
-
Table GE healthcare Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Hoffman-La Roche Ltd Company Profile
-
Table Hoffman-La Roche Ltd Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table H Lundbeck A/S Company Profile
-
Table H Lundbeck A/S Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceuticals Industries Ltd Company Profile
-
Table Teva Pharmaceuticals Industries Ltd Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Eisai Co Ltd Company Profile
-
Table Eisai Co Ltd Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table TauRx Pharmaceuticals Ltd Company Profile
-
Table TauRx Pharmaceuticals Ltd Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly And Company Company Profile
-
Table Eli Lilly And Company Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table AC Immune Company Profile
-
Table AC Immune Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Pfizer, Inc Company Profile
-
Table Pfizer, Inc Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Actavis plc Company Profile
-
Table Actavis plc Alzheimer’s Therapeutics Revenue, Price and Gross (2018-2023)
-
